“…GSH in tumor cells, which is an antioxidant substance, can reduce the reactive oxygen species (ROS) and cytotoxicity, thereby reducing the effect of ROS-based treatment. 23,40,41 Cu 2+ can effectively convert GSH to GSSH, while itself being reduced to Cu + , thereby reducing the GSH content, and enhancing the ROS-based treatment effect. [24][25][26][27][28][29][30][31][32][33] Similarly, this "Cu storage pool" also may be capable of releasing Cu 2+ (Fig.…”